Matches in Wikidata for { <http://www.wikidata.org/entity/Q72361047> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q72361047 description "article scientifique publié en 1994" @default.
- Q72361047 description "artículu científicu espublizáu en mayu de 1994" @default.
- Q72361047 description "im Mai 1994 veröffentlichter wissenschaftlicher Artikel" @default.
- Q72361047 description "scientific article published on 01 May 1994" @default.
- Q72361047 description "wetenschappelijk artikel" @default.
- Q72361047 description "наукова стаття, опублікована в травні 1994" @default.
- Q72361047 name "Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatment" @default.
- Q72361047 name "Stearyl-norleucine-vasoactive intestinal peptide" @default.
- Q72361047 type Item @default.
- Q72361047 label "Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatment" @default.
- Q72361047 label "Stearyl-norleucine-vasoactive intestinal peptide" @default.
- Q72361047 prefLabel "Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatment" @default.
- Q72361047 prefLabel "Stearyl-norleucine-vasoactive intestinal peptide" @default.
- Q72361047 P1433 Q72361047-3CE851BE-3E32-4185-BDA9-8C0DA2BE5C13 @default.
- Q72361047 P1476 Q72361047-961A262E-EF1A-47DA-93CA-2814F29454CD @default.
- Q72361047 P2093 Q72361047-01320128-5C7A-4D86-B5A4-F6F09A4C4D8B @default.
- Q72361047 P2093 Q72361047-508CB777-878B-403F-903A-A7FB51E5A238 @default.
- Q72361047 P2093 Q72361047-86F0ECA8-5B2E-481B-A583-DD0D218DE70F @default.
- Q72361047 P2093 Q72361047-B2C8B908-345F-4C05-9262-6400AE75E345 @default.
- Q72361047 P2093 Q72361047-C7F4642B-3B66-4F9F-995D-75E8D3E38A5D @default.
- Q72361047 P304 Q72361047-176685BF-50E6-4CE0-825B-BB6F41E44269 @default.
- Q72361047 P31 Q72361047-7CBE7A8A-757E-4349-9E90-7F273C3397DB @default.
- Q72361047 P356 Q72361047-400DF7AF-0D0D-408E-8BE4-1483A41E29E6 @default.
- Q72361047 P407 Q72361047-653FC567-E31A-437B-91A8-65CC455AD225 @default.
- Q72361047 P433 Q72361047-39E0DCFA-0A8D-4CF5-A158-FBD6C3D81339 @default.
- Q72361047 P478 Q72361047-6DC8F9C3-E492-45ED-B626-F0199034194B @default.
- Q72361047 P577 Q72361047-D98255C6-0A06-44C2-BD31-EC96944491FE @default.
- Q72361047 P698 Q72361047-39052D06-6EBC-420C-923E-F58AD2695D3A @default.
- Q72361047 P921 Q72361047-AAB39C8A-13D0-42CB-9467-7A9FB4F8ACA0 @default.
- Q72361047 P356 ENDO.134.5.8156912 @default.
- Q72361047 P698 8156912 @default.
- Q72361047 P1433 Q3054009 @default.
- Q72361047 P1476 "Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatment" @default.
- Q72361047 P2093 "Fridkin M" @default.
- Q72361047 P2093 "Gozes I" @default.
- Q72361047 P2093 "Reshef A" @default.
- Q72361047 P2093 "Rubinraut S" @default.
- Q72361047 P2093 "Salah D" @default.
- Q72361047 P304 "2121-2125" @default.
- Q72361047 P31 Q13442814 @default.
- Q72361047 P356 "10.1210/ENDO.134.5.8156912" @default.
- Q72361047 P407 Q1860 @default.
- Q72361047 P433 "5" @default.
- Q72361047 P478 "134" @default.
- Q72361047 P577 "1994-05-01T00:00:00Z" @default.
- Q72361047 P698 "8156912" @default.
- Q72361047 P921 Q184674 @default.